Cancer research
Researchers in the United States conducted an unbiased screening to investigate the transcriptional targets of ZKSCAN3, a zinc finger protein involved in colon cancer progression. The study employed cyclic amplification and selection of targets using a random oligonucleotide library and ZKSCAN3 protein, identifying a DNA recognition motif and candidate downstream
Cancer
Researchers at Sichuan University have discovered that the matrix protein of vesicular stomatitis virus (VSV) can induce remarkable apoptosis of cancer cells and initiate an immune response, leading to an extraordinary antitumor effect. This study provides promising results for the development of a novel cancer gene therapy agent. The researchers
Cancer
Prostate cancer, particularly androgen-independent (AI) forms, poses a significant challenge in treatment. Researchers have been exploring alternative therapeutic approaches, including enzyme pro-drug suicide gene therapy. A recent study published in Cancer Gene Therapy by Ahn and colleagues from Indiana University, Medical Department, presents a promising solution. The scientists developed AdIU1,
Cancer research
Researchers from the Peking Union Medical College have made a significant breakthrough in cancer gene therapy, discovering a novel mechanism by which MR-1 modulates cell proliferation and migration in human hepatoma HepG2 cells. According to their study, published in the Journal of Biological Chemistry, MR-1 is overexpressed in human hepatoma
Cancer research
In a groundbreaking study, researchers in Seoul, South Korea, have successfully used human umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) as gene delivery vehicles for glioma therapy. The team, led by S.M. Kim and colleagues from Catholic University, engineered UCB-MSCs to deliver a secretable trimeric form of tumor necrosis
Cancer
Despite significant advances in cancer treatment, the 5-year survival rate for patients with distant metastases of melanoma remains less than 10%. Patients with advanced melanoma often receive systemic therapy, with single-agent cytotoxic chemotherapy using dacarbazine as the standard of care in community practice. However, the response rate is generally low,
Cancer research
Researchers at the Beijing Institute Radiation Medical in the People's Republic of China have made significant progress in developing a novel adenovirus-mediated gene therapy for nasopharyngeal carcinoma (NPC), a type of head and neck cancer. The study, published in Cancer Biotherapy and Radiopharmaceuticals, demonstrated the efficacy of combining
Cancer
Scientists in Tokyo, Japan, have made a groundbreaking discovery in the field of cancer research, identifying a potential molecular target for the diagnosis, treatment, and prevention of lung and esophageal carcinomas. By analyzing gene expression profiles of 101 lung cancers and 19 esophageal squamous cell carcinomas, researchers isolated the epithelial
Cancer research
Researchers have found that a combination of antiangiogenesis with chemotherapy may lead to more effective cancer treatment, as reported in a recent study published in Molecular Cancer Therapeutics. According to the study, angiogenesis is a hallmark of tumor development and metastasis, and antiangiogenic drugs have shown modest survival benefits. However,
Cancer
Scientists at Yunnan University in the People's Republic of China have discovered that endophytic streptomycetes isolated from pharmaceutical plants in the rainforest exhibit remarkable and diverse antitumour and antimicrobial bioactivities. The researchers isolated 41 endophytic actinomycetes from pharmaceutical plants in the rainforest and screened them for antitumour and
Cancer research
Researchers in the United States have reported a study that confirms the accuracy of gene expression signatures in predicting survival rates in non-small cell lung cancer (NSCLC) patients. The study, published in Clinical Cancer Research, suggests that a 35-gene signature can effectively stratify patients into high-and low-risk groups, with distinct
Cancer
Researchers from the University of Sydney's Department of Surgery have made significant progress in identifying a potential therapeutic target for prostate cancer, according to a report published in Clinical Cancer Research. The study focuses on cytosolic phospholipase A2-alpha (cPLA2-alpha), an enzyme that plays a crucial role in the
